• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗马 III、罗马 IV 及可能的亚洲功能性消化不良症状标准并不能可靠地区分功能性与器质性疾病。

Rome III, Rome IV, and Potential Asia Symptom Criteria for Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease.

机构信息

Department of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University, Shaanxi, China.

Department of Gastroenterology, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.

出版信息

Clin Transl Gastroenterol. 2020 Dec;11(12):e00278. doi: 10.14309/ctg.0000000000000278.

DOI:10.14309/ctg.0000000000000278
PMID:33512804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7721216/
Abstract

INTRODUCTION

Although the Rome criteria were created primarily for research purposes, it was an important question whether the Rome criteria can distinguish organic dyspepsia from functional dyspepsia (FD). We evaluated the accuracy of the Rome IV criteria in identifying patients with FD and compared the differences between the Rome IV, Rome III, and potential Asia criteria in identifying patients with FD.

METHODS

In this cross-sectional study, we analyzed data from patients who met the inclusion and exclusion criteria from March 2018 to January 2019 at 2 tertiary hospitals.

RESULTS

A total of 600 patients were enrolled in this study, including 381 individuals met the Rome IV criteria for FD, 438 individuals met the Rome III criteria for FD, and 525 individuals met the potential Asia criteria for FD. The Rome IV criteria identified patients with FD with 67.3% sensitivity and 38.4% specificity, and the positive and negative likelihood ratios of FD identified by Rome IV criteria were 1.09 (95% confidence interval 0.97-1.24) and 0.85 (95% confidence interval 0.67-1.08), respectively. There was no significant difference in the area under Rome IV, Rome III, or potential Asia criteria receiver operating characteristic curves in identifying FD (P > 0.05).

DISCUSSION

The Rome IV criteria were no better than the Rome III or potential Asia criteria in identifying FD and were not helpful in identifying patients with FD. Hence, although the Rome criteria remain useful for defining patients with FD for inclusion into clinical treatment trials, they should not be used for diagnosing FD.

摘要

简介

尽管罗马标准主要是为研究目的而制定的,但罗马标准能否区分器质性消化不良和功能性消化不良(FD)是一个重要问题。我们评估了罗马 IV 标准识别 FD 患者的准确性,并比较了罗马 IV、罗马 III 和潜在亚洲标准在识别 FD 患者方面的差异。

方法

在这项横断面研究中,我们分析了 2018 年 3 月至 2019 年 1 月期间 2 家 3 级医院符合纳入和排除标准的患者数据。

结果

共有 600 名患者纳入本研究,其中 381 名符合罗马 IV 标准的 FD 患者,438 名符合罗马 III 标准的 FD 患者,525 名符合潜在亚洲标准的 FD 患者。罗马 IV 标准对 FD 的诊断敏感度为 67.3%,特异度为 38.4%,罗马 IV 标准诊断 FD 的阳性和阴性似然比分别为 1.09(95%置信区间为 0.97-1.24)和 0.85(95%置信区间为 0.67-1.08)。在识别 FD 方面,罗马 IV、罗马 III 或潜在亚洲标准的曲线下面积无显著差异(P>0.05)。

讨论

罗马 IV 标准在识别 FD 方面并不优于罗马 III 或潜在亚洲标准,也无助于识别 FD 患者。因此,尽管罗马标准在将 FD 患者纳入临床治疗试验的定义方面仍然有用,但不应用于 FD 的诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03c/7721216/d6899d513d11/ct9-11-e00278-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03c/7721216/70021f6722fd/ct9-11-e00278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03c/7721216/d6899d513d11/ct9-11-e00278-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03c/7721216/70021f6722fd/ct9-11-e00278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e03c/7721216/d6899d513d11/ct9-11-e00278-g006.jpg

相似文献

1
Rome III, Rome IV, and Potential Asia Symptom Criteria for Functional Dyspepsia Do Not Reliably Distinguish Functional From Organic Disease.罗马 III、罗马 IV 及可能的亚洲功能性消化不良症状标准并不能可靠地区分功能性与器质性疾病。
Clin Transl Gastroenterol. 2020 Dec;11(12):e00278. doi: 10.14309/ctg.0000000000000278.
2
The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions.罗马 III 标准在二级医疗保健中对功能性消化不良的诊断并不优于以往的定义。
Gastroenterology. 2014 Apr;146(4):932-40; quiz e14-5. doi: 10.1053/j.gastro.2014.01.014. Epub 2014 Jan 11.
3
Comparing diagnostic performance of Cantonese-Chinese version of Rome IV criteria and a short Reference Standard for functional dyspepsia in China.比较中文(粤语版)罗马 IV 标准与中国短参考标准对功能性消化不良的诊断性能。
BMC Gastroenterol. 2022 Oct 12;22(1):432. doi: 10.1186/s12876-022-02520-6.
4
Discriminant value of Rome III questionnaire in dyspeptic patients.罗马 III 问卷在消化不良患者中的鉴别价值。
Saudi J Gastroenterol. 2011 Mar-Apr;17(2):129-33. doi: 10.4103/1319-3767.77244.
5
Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study.罗马 IV 型肠易激综合征与功能性消化不良重叠及对自然病程的影响:一项纵向随访研究。
Clin Gastroenterol Hepatol. 2022 Feb;20(2):e89-e101. doi: 10.1016/j.cgh.2021.04.011. Epub 2021 Apr 9.
6
Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.儿童疼痛相关功能性胃肠疾病的竞争性诊断模型研究。
Neurogastroenterol Motil. 2017 Nov;29(11). doi: 10.1111/nmo.13126. Epub 2017 Jun 28.
7
Predictive value of alarm symptoms in patients with Rome IV dyspepsia: A cross-sectional study.罗马IV型消化不良患者报警症状的预测价值:一项横断面研究。
World J Gastroenterol. 2020 Aug 14;26(30):4523-4536. doi: 10.3748/wjg.v26.i30.4523.
8
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria.根据罗马III标准,功能性消化不良亚组中的不同病因发病机制。
Gut. 2015 Oct;64(10):1517-28. doi: 10.1136/gutjnl-2014-308114. Epub 2014 Nov 18.
9
Epidemiology and Clinical Characteristics Based on the Rome III and IV Criteria of Japanese Patients with Functional Dyspepsia.基于罗马III和IV标准的日本功能性消化不良患者的流行病学及临床特征
J Clin Med. 2022 Apr 22;11(9):2342. doi: 10.3390/jcm11092342.
10
Effects of the Rome IV Criteria to Functional Dyspepsia Symptoms in Saudi Arabia: Epidemiology and Clinical Practice.罗马 IV 标准对沙特阿拉伯功能性消化不良症状的影响:流行病学和临床实践。
Korean J Gastroenterol. 2020 Dec 25;76(6):304-313. doi: 10.4166/kjg.2020.110.

引用本文的文献

1
The impact of relaxing the requirements for dyspeptic Symptom Onset frequency or duration in Rome IV Criteria on the Symptom Pattern and diagnosis of functional dyspepsia.罗马 IV 标准中放宽消化不良症状起始频率或持续时间的要求对功能性消化不良的症状模式和诊断的影响。
BMC Gastroenterol. 2024 Nov 5;24(1):393. doi: 10.1186/s12876-024-03486-3.
2
Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic?长期消化不良症状——新冠疫情的又一后果?
Prz Gastroenterol. 2023;18(2):175-182. doi: 10.5114/pg.2023.129414. Epub 2023 Jul 27.
3
Comparing diagnostic performance of Cantonese-Chinese version of Rome IV criteria and a short Reference Standard for functional dyspepsia in China.

本文引用的文献

1
The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia population.理气健脾汤对胃肠症状和胃动力功能的影响:在比利时功能性消化不良人群中的首次研究。
Neurogastroenterol Motil. 2020 Feb;32(2):e13739. doi: 10.1111/nmo.13739. Epub 2019 Oct 14.
2
Benefits and Pitfalls of Change From Rome III to Rome IV Criteria for Irritable Bowel Syndrome and Fecal Incontinence.肠易激综合征和大便失禁从罗马Ⅲ标准转变为罗马Ⅳ标准的益处与缺陷
Clin Gastroenterol Hepatol. 2020 Feb;18(2):297-299. doi: 10.1016/j.cgh.2019.10.004. Epub 2019 Oct 10.
3
Drugs under development for the treatment of functional dyspepsia and related disorders.
比较中文(粤语版)罗马 IV 标准与中国短参考标准对功能性消化不良的诊断性能。
BMC Gastroenterol. 2022 Oct 12;22(1):432. doi: 10.1186/s12876-022-02520-6.
4
The Role of Gastrointestinal Microbiota in Functional Dyspepsia: A Review.胃肠道微生物群在功能性消化不良中的作用:综述
Front Physiol. 2022 Jun 8;13:910568. doi: 10.3389/fphys.2022.910568. eCollection 2022.
5
Evaluation of QOL in Patients with Dyspeptic Symptoms Who Meet or Do Not Meet Rome IV Criteria.符合或不符合罗马IV标准的消化不良症状患者的生活质量评估。
J Clin Med. 2021 Dec 22;11(1):21. doi: 10.3390/jcm11010021.
6
Electroacupuncture Regulates TRPV1 through PAR2/PKC Pathway to Alleviate Visceral Hypersensitivity in FD Rats.电针通过PAR2/PKC通路调节TRPV1以减轻功能性消化不良大鼠的内脏高敏感性
Evid Based Complement Alternat Med. 2021 Nov 29;2021:1975228. doi: 10.1155/2021/1975228. eCollection 2021.
正在开发用于治疗功能性消化不良和相关疾病的药物。
Expert Opin Investig Drugs. 2019 Oct;28(10):871-889. doi: 10.1080/13543784.2019.1673365. Epub 2019 Oct 8.
4
Eradication Therapy for Functional Dyspepsia: A Meta-Analysis by Region and Prevalence.功能性消化不良的根除治疗:按地区和患病率进行的荟萃分析
J Clin Med. 2019 Aug 28;8(9):1324. doi: 10.3390/jcm8091324.
5
Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.基于罗马 IV 标准与罗马 III 标准比较的自报肠易激综合征患者的流行病学、临床和心理学特征。
Clin Gastroenterol Hepatol. 2020 Feb;18(2):392-398.e2. doi: 10.1016/j.cgh.2019.05.037. Epub 2019 May 31.
6
How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors.罗马 III 标准向罗马 IV 标准转变如何影响 IBS 的临床特征和关键病理生理因素。
Am J Gastroenterol. 2018 Jul;113(7):1017-1025. doi: 10.1038/s41395-018-0074-z. Epub 2018 Jun 8.
7
The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study.用于胃灼热诊断的罗马IV与罗马III标准:一项对比研究。
United European Gastroenterol J. 2018 Apr;6(3):358-366. doi: 10.1177/2050640617735084. Epub 2017 Sep 27.
8
Prevalence of Functional Gastrointestinal Disorders in Children and Adolescents: Comparison Between Rome III and Rome IV Criteria.儿童和青少年功能性胃肠疾病的患病率:罗马 III 标准与罗马 IV 标准的比较。
J Pediatr. 2018 Aug;199:212-216. doi: 10.1016/j.jpeds.2018.03.037. Epub 2018 May 7.
9
Management of Dyspepsia.消化不良的管理
JAMA. 2018 May 1;319(17):1816-1817. doi: 10.1001/jama.2018.3435.
10
Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.使用罗马III标准与罗马IV标准对与腹痛相关的儿童功能性胃肠疾病进行分类。
BMC Gastroenterol. 2018 Mar 17;18(1):41. doi: 10.1186/s12876-018-0769-z.